昌興國際(00803.HK):擬訂於11月11日就索償進行聆訊
格隆匯 10 月 6日丨昌興國際(00803.HK)發佈公告,2020年9月28日,上海市徐彙區人民法院分別向公司間接全資附屬公司浙江昌興投資有限公司(“浙江昌興”)及公司擁有55%的間接附屬公司蘇州市嘉欣房地產開發有限公司(“蘇州嘉欣”)出具傳票。
根據傳票,徐彙區人民法院已接受劉曉霞(作為原告)針對(其中包括)(i)浙江昌興結欠原告並由蘇州嘉欣作為擔保的指稱未支付未償還本金、應計利息及貸款費用合共約人民幣2326.58萬元;及(ii)指稱違約罰款人民幣400萬元而向浙江昌興(作為第一被告)及蘇州嘉欣(作為第二被告)各自提出的索償。擬訂於2020年11月11日就索償進行聆訊。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.